MUMBAI, India, July 30 -- Intellectual Property India has published a patent application (202621067369 A) filed by Svkms Nmims Shobhaben Pratapbhai Patel School Of Pharmacy And Technology Management on May 29, 2026, for Solid Lipid Nanoparticle Composition Of Benztropine Mesylate For Intranasal Administration And Process Thereof.
Inventors include Dr Khushwant Yadav; and Mr Vipul Mittal.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: Solid Lipid Nanoparticle Composition of Benztropine Mesylate for Intranasal Administration and process thereof A pharmaceutical composition for intranasal administration comprising benztropine mesylate as an active pharmaceutical ingredient, a solid lipid, a surfactant, a co-surfactant, and an aqueous vehicle, wherein the benztropine mesylate is encapsulated within solid lipid nanoparticles. The composition belongs to the technical field of pharmaceutical formulations for intranasal drug delivery. The solid lipid nanoparticle formulation provides brain-targeted delivery of benztropine mesylate via the intranasal route, bypassing the blood-brain barrier through nasal pathways. The composition may be used in the treatment of Parkinson's disease
Disclaimer: Curated by HT Syndication.
